ABT Abbott Laboratories | US0028241000
| Metric | Current | 30.06.2026 | 31.03.2026 | 31.12.2025 | 30.09.2025 |
|---|---|---|---|---|---|
| Market Cap | 179.511.263.232 | 158.052.121.873,05 | 178.831.953.331,82 | 217.578.546.805,69 | 232.904.512.826,47 |
| Enterprise Value | 206.992.195.584 | 158.052.121.873,05 | 206.075.953.331,82 | 222.916.546.805,69 | 238.334.512.826,47 |
| Trailing P/E | 33,35 | 35,15 | 28,49 | 33,35 | 49,05 |
| Forward P/E | 16,99 | - | - | - | - |
| Price to Sales | 3,85 | 4,65 | 3,96 | 4,91 | 7,09 |
| Price to Book | 3,45 | - | 3,44 | 4,17 | 4,57 |
| EV/Revenue | 4,44 | 4,65 | 4,57 | 5,03 | 7,25 |
| EV/EBITDA | 17,44 | 18,08 | 17,49 | 18,54 | 27,18 |